Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME study: Rupatadine potency on nasal symptoms induced by multiple pollen exposure in OHIO chamber
jRCTs031190037Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rupatadine in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoint: Time course of Total Nasal Symptoms Score. Started Jun 2019; status: completed.
02
Drugs
rupatadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on jRCTs031190037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190037.